Modern perspectives in sequential therapy for metastatic colorectal cancer with reference to the use of regorafenib
Over the past two decades, many new variants of targeted therapy for metastatic colorectal cancer (mCRC) had appeared, and significantly increased patient survival. However, there were questions relating to the definition of the optimal sequence and the combination of different drugs. Cytotoxic agen...
Enregistré dans:
Auteurs principaux: | M. I. Sekacheva, R. I. Nuriev, A. A. Rozhkov, A. V. Semenkov, N. N. Bagmet, A. M. Boroda |
---|---|
Format: | article |
Langue: | RU |
Publié: |
IP Habib O.N.
2020
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/5e4f261f79964feabb01d7d3d9dc1d9c |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Regorafenib in metastatic colorectal cancer: more data for clinical decisions
par: Vladislav V. Petkau, et autres
Publié: (2021) -
Refractory metastatic colorectal cancer: challenges and solutions during the COVID-19 pandemic
par: Marina I. Sekacheva, et autres
Publié: (2021) -
A Promising Role of TGF-β Pathway in Response to Regorafenib in Metastatic Colorectal Cancer: A Case Report
par: Simona De Summa, et autres
Publié: (2021) -
Preliminary Efficacy and Safety of Camrelizumab in Combination With XELOX Plus Bevacizumab or Regorafenib in Patients With Metastatic Colorectal Cancer: A Retrospective Study
par: Hong Zhou, et autres
Publié: (2021) -
SHORT-TERM RESULTS OF SIMULTANEOUS SURGERIES AT METASTATIC COLORECTAL CANCER
par: A. S. Zagaynov, et autres
Publié: (2017)